Mukesh Kumar Agarwal

Invenio Therapeutics, Inc.

$2,352,941

Attributed

$3,099,734

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $775.8K · FY2008–16

$1M$750K$500K$250K$0

'08

'09

'10

'11

'12

'13

'14

'15

'16

Funding mix

By agency

NIH$3,099,734 · 6

By mechanism

R44$2,481,038 · 2

R43$618,696 · 4

Top collaborators

David Wald2 shared

Others in their field

Top investigators on “In Vitro”

David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
Mark S Klempner · Tufts Medical Center$128,021,180
Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
Dennis R. Burton · Scripps Research Institute$79,204,175

Research focus

In VitroMalignant NeoplasmsToxic EffectLeukemiaCellsDrug KineticsLeukemic CellSamplingChemotherapyLeadExhibitsClinical TrialsBiologyLeukemia, Myelocytic, AcuteNovel TherapeuticsHematopoieticIn VivoPublic Health Medicine (Field)EnsureAdultMyeloid CellsDifferentiation TherapyAcuteLife